Literature DB >> 25335735

Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population.

Xueren Gao1, Shulong Zhang2, Zhansheng Zhu3.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is the most common cancer worldwide. Both genetic and environmental factors play an important role in pathogenesis of CRC, susceptibility may be modified by functional polymorphisms in receptor tyrosine kinase genes, such as ErbB4. We here evaluated whether a 12-bp insertion/deletion (indel) polymorphism (rs6147150) in the 3'UTR of ErbB4 could potentially affect the occurrence of CRC in Chinese population.
METHODS: We studied the genotypic and allelic frequencies of ErbB4 polymorphism in 399 patients with CRC and 419 control participants using polymerase chain reaction and polyacrylamide gel electrophoresis method.
RESULTS: Under co-dominant model, we found that the del/del genotype of indel was associated with a significantly increased risk of CRC compared with its homozygote ins/ins (adjusted OR=1.70, 95%CI=1.06-2.71). Under recessive model, carrying of del/del genotype conferred a significantly increased risk for CRC compared with ins/ins and ins/del genotype (adjusted OR=1.60, 95%CI=1.03-2.50). Presence of 12-bp deletion allele of ErbB4 seemed to confer higher risk for CRC when compared with non-carriers (adjusted OR=1.27, 95%CI=1.02-1.57). Further stratification analysis showed that this association was more pronounced in patients with drinking.
CONCLUSION: Our data suggested that individuals in Chinese population with the ErbB4 12-bp deletion allele may be at higher risk for CRC, rs6147150 would potentially be a promising novel biomarker for CRC susceptibility. Further validation of our results in larger populations and studies with functional assays are required.

Entities:  

Keywords:  Colorectal cancer; ErbB4; polymorphism; susceptibility

Mesh:

Substances:

Year:  2014        PMID: 25335735     DOI: 10.3233/CBM-140420

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  3 in total

1.  Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.

Authors:  Wan-Ping Wang; Hai-Bo Bian; Xia-Zhen Wang; Liang Liu; Ding Wei
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

2.  Pri-miR-124 rs531564 polymorphism and colorectal cancer risk.

Authors:  Xue-Ren Gao; Hui-Ping Wang; Shu-Long Zhang; Ming-Xi Wang; Zhan-Sheng Zhu
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

3.  Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.

Authors:  Diego Marques; Layse Raynara Ferreira-Costa; Lorenna Larissa Ferreira-Costa; Romualdo da Silva Correa; Aline Maciel Pinheiro Borges; Fernanda Ribeiro Ito; Carlos Cesar de Oliveira Ramos; Raul Hernandes Bortolin; André Ducati Luchessi; Ândrea Ribeiro-Dos-Santos; Sidney Santos; Vivian Nogueira Silbiger
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.